| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.91▲ | 11.91▼ | 11.92▼ | 11.72▲ | 11.06▲ |
| MA10 | 11.90▲ | 11.92▼ | 11.85▲ | 11.22▲ | 10.48▲ |
| MA20 | 11.88▲ | 11.76▲ | 11.65▲ | 10.56▲ | 11.09▲ |
| MA50 | 11.62▲ | 11.53▲ | 11.28▲ | 10.47▲ | 13.08▼ |
| MA100 | 11.46▲ | 11.00▲ | 10.72▲ | 11.18▲ | N/A |
| MA200 | 10.84▲ | 10.44▲ | 10.25▲ | 12.53▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | 0.001▲ | 0.002▲ | 0.202▲ | N/A |
| RSI | 55.254▲ | 59.552▲ | 61.718▲ | 60.388▲ | N/A |
| STOCH | 54.802 | 65.411 | 75.819 | 81.568▲ | 53.889 |
| WILL %R | -44.828 | -30.233 | -20.000▲ | -5.372▲ | -35.770 |
| CCI | -9.733 | 42.315 | 61.535 | 117.282▲ | 69.683 |
|
Wednesday, February 13, 2019 07:20 PM
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that Terry ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/02/19 | 11.75 | 12.00 | 11.75 | 11.91 | 36,780 |
| 21/02/19 | 11.57 | 12.04 | 11.33 | 11.99 | 35,645 |
| 20/02/19 | 11.21 | 11.70 | 11.21 | 11.60 | 35,612 |
| 19/02/19 | 11.79 | 12.00 | 11.15 | 11.21 | 58,787 |
| 15/02/19 | 10.83 | 11.98 | 10.39 | 11.89 | 95,775 |
| 14/02/19 | 10.99 | 11.75 | 10.66 | 10.75 | 70,402 |
| 13/02/19 | 10.51 | 11.26 | 10.43 | 11.16 | 60,674 |
| 12/02/19 | 10.56 | 10.84 | 10.26 | 10.41 | 49,993 |
| 11/02/19 | 10.93 | 10.93 | 10.31 | 10.44 | 32,558 |
| 08/02/19 | 10.06 | 10.99 | 10.06 | 10.81 | 85,638 |
|
|
||||
|
|
||||
|
|
||||
|
|